Alphabet’s DeepMind Spins Out Isomorphic Labs to Use AI for Drug Discovery
Isomorphic Labs, which will use artificial intelligence — AI — for drug discovery, will be the latest Alphabet company after being spun out of the firm’s DeepMind project, according to a blog post. Isomorphic Labs is described as “a commercial venture with the mission to reimagine the entire drug discovery process from first principles with …
Alphabet’s DeepMind Spins Out Isomorphic Labs to Use AI for Drug Discovery Read More »